RUNX1 and acute myeloid leukemia: The HDACis AR-42, belinostat, trichostatin A, and entinostat preferentially affect the proliferation of EVI1High AML cells compared to EVI1Low, suggesting that EVI1 sensitizes 3q26 AML cells to HDACi-mediated cytotoxicity (Supplementary Fig. 1D).